The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.
Saved in:
| Title: | The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. |
|---|---|
| Authors: | Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. caroline.tanner@ucsf.edu.; Parkinson's Disease Research Education and Clinical Center, San Francisco Veteran's Affairs Health Care System, San Francisco, CA, USA. caroline.tanner@ucsf.edu., Cummings SR; San Francisco Coordinating Center,California Pacific Medical Center Research Institute, Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Schwarzschild MA; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Brown EG; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA., Dorsey ER; Center for Health + Technology and Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA., Espay AJ; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA., Galifianakis NB; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA., Goldman SM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.; Division of Occupational and Environmental Medicine, University of California San Francisco, San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA., Litvan I; Parkinson and Other Movement Disorders Center, Department of Neuroscience, University of California San Diego, La Jolla, CA, USA., Luthra N; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA., McFarland NR; Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA., Mitchell KT; Department of Neurology, Duke University School of Medicine, Durham, NC, USA., Standaert DG; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Bauer DC; Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Greenspan SL; Osteoporosis Prevention and Treatment Center, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Beck JC; Parkinson's Foundation, New York, NY, USA., Lyles KW; Department of Medicine, Duke University School of Medicine, VA Medical Center, Durham, NC, USA. |
| Source: | NPJ Parkinson's disease [NPJ Parkinsons Dis] 2021 Mar 01; Vol. 7 (1), pp. 16. Date of Electronic Publication: 2021 Mar 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
